Immunovant, Inc. (IMVT)
22.76
-0.40
(-1.75%)
USD |
NASDAQ |
Dec 09, 16:00
22.87
+0.10
(+0.46%)
After-Hours: 18:50
Immunovant Total Assets (Quarterly): 582.96M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Revvity, Inc. | 12.14B |
| Perspective Therapeutics, Inc. | 294.82M |
| Electromed, Inc. | 53.61M |
| Xtant Medical Holdings, Inc. | 106.32M |
| VolitionRX Ltd. | 6.449M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 63.25M |
| Shareholders Equity (Quarterly) | 519.70M |
| Current Ratio | 9.067 |
| Net Debt Paydown Yield | 0.00% |